TABUTEAU HERRIOT

Track

Insider profile

TABUTEAU HERRIOT's trades of Axsome Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-09 2026-06-09
PlS Planned sale
49,600 -35.4%
197.07
US$1,857,209 		49,600 -35.4% 197.07 US$1,857,209
2026-06-09 2026-06-09
PrS Proposed sale
70,639
286.13
US$587,522 		70,639 286.13 US$587,522
2026-02-02 2026-02-02
PrS Proposed sale
26,000
329.10
US$2,619,384 		26,000 329.10 US$2,619,384
2026-02-02 2026-02-02
PlS Planned sale
32,410 -81.8%
185.60
US$6,015,296 		32,410 -81.8% 185.60 US$6,015,296
2026-01-07 2026-01-07
PrS Proposed sale
31,261
170.69
US$5,335,940 		31,261 170.69 US$5,335,940
2026-01-07 2026-01-07
PlS Planned sale
31,261 -81.2%
170.38
US$5,326,249 		31,261 -81.2% 170.38 US$5,326,249
2026-01-07 2026-01-06
PlS Planned sale
29,450 -80.3%
172.33
US$5,075,118 		29,450 -80.3% 172.33 US$5,075,118
2026-01-06 2026-01-06
PrS Proposed sale
29,450
171.88
US$5,061,866 		29,450 171.88 US$5,061,866
2026-01-07 2026-01-05
PlS Planned sale
78,703 -91.6%
171.28
US$13,480,250 		78,703 -91.6% 171.28 US$13,480,250
2026-01-05 2026-01-05
PrS Proposed sale
78,703
171.49
US$13,496,777 		78,703 171.49 US$13,496,777
2025-12-04 2025-12-04
PrS Proposed sale
10,558
148.04
US$1,563,006 		10,558 148.04 US$1,563,006
2025-12-04 2025-12-04
PlS Planned sale
10,558 -59.4%
148.18
US$1,564,484 		10,558 -59.4% 148.18 US$1,564,484
2025-12-04 2025-12-03
PlS Planned sale
20,163 -73.6%
146.94
US$2,962,751 		20,163 -73.6% 146.94 US$2,962,751
2025-12-03 2025-12-03
PrS Proposed sale
20,163
147.81
US$2,980,293 		20,163 147.81 US$2,980,293
2025-12-04 2025-12-02
PlS Planned sale
49,252 -87.2%
144.59
US$7,121,347 		49,252 -87.2% 144.59 US$7,121,347
2025-12-02 2025-12-02
PrS Proposed sale
49,252
142.09
US$6,998,217 		49,252 142.09 US$6,998,217
2025-11-05 2025-11-05
PrS Proposed sale
21,775
135.69
US$2,954,650 		21,775 135.69 US$2,954,650
2025-11-05 2025-11-05
PlS Planned sale
21,775 -75.1%
134.49
US$2,928,520 		21,775 -75.1% 134.49 US$2,928,520
2025-11-05 2025-11-04
PlS Planned sale
50,459 -87.5%
133.79
US$6,750,910 		50,459 -87.5% 133.79 US$6,750,910
2025-11-04 2025-11-04
PrS Proposed sale
50,459
134.93
US$6,808,433 		50,459 134.93 US$6,808,433
2025-11-05 2025-11-03
PlS Planned sale
91,705 -92.7%
132.34
US$12,136,240 		91,705 -92.7% 132.34 US$12,136,240
2025-11-03 2025-11-03
PrS Proposed sale
91,705
135.75
US$12,448,954 		91,705 135.75 US$12,448,954
2025-10-08 2025-10-08
PrS Proposed sale
12,774
118.71
US$1,516,402 		12,774 118.71 US$1,516,402
2025-10-08 2025-10-08
PlS Planned sale
12,774 -63.9%
118.84
US$1,518,062 		12,774 -63.9% 118.84 US$1,518,062
2025-10-08 2025-10-07
PlS Planned sale
13,390 -64.9%
118.77
US$1,590,330 		13,390 -64.9% 118.77 US$1,590,330
2025-10-07 2025-10-07
PrS Proposed sale
13,390
118.64
US$1,588,590 		13,390 118.64 US$1,588,590
2025-10-08 2025-10-06
PlS Planned sale
19,220 -72.7%
120.17
US$2,309,667 		19,220 -72.7% 120.17 US$2,309,667
2025-10-06 2025-10-06
PrS Proposed sale
19,220
119.94
US$2,305,247 		19,220 119.94 US$2,305,247
2025-09-16 2025-09-16
PrS Proposed sale
19,719
114.10
US$2,249,938 		19,719 114.10 US$2,249,938
2025-09-16 2025-09-16
PlS Planned sale
19,719 -73.2%
114.19
US$2,251,713 		19,719 -73.2% 114.19 US$2,251,713
2025-09-16 2025-09-15
PlS Planned sale
15,254 -67.8%
117.37
US$1,790,362 		15,254 -67.8% 117.37 US$1,790,362
2025-09-15 2025-09-15
PrS Proposed sale
15,254
116.78
US$1,781,286 		15,254 116.78 US$1,781,286
2025-09-16 2025-09-12
PlS Planned sale
27,907 -79.4%
118.96
US$3,319,817 		27,907 -79.4% 118.96 US$3,319,817
2025-09-12 2025-09-12
PrS Proposed sale
27,907
118.42
US$3,304,747 		27,907 118.42 US$3,304,747